Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Critical flicker frequency for diagnosis of minimal hepatic encephalopathy

A study published ahead of print in the Alimentary Pharmacology & Therapeutics reviews the diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy.

News image

Minimal hepatic encephalopathy reduces quality of life, increases the risk of road traffic incidents and predicts progression to overt hepatic encephalopathy and death.

Current psychometry-based diagnostic methods are effective, but time-consuming and a universal ‘gold standard’ test has yet to be agreed upon.

The Critical Flicker Frequency is a proposed language-independent diagnostic tool for Minimal hepatic encephalopathy, but its accuracy has yet to be confirmed.

Professor Taylor-Robinson and colleagues from the United Kingdom assessed the diagnostic accuracy of Critical Flicker Frequency for minimal hepatic encephalopathy by performing a systematic review and meta-analysis of all studies, which report on the diagnostic accuracy of this test.

The research team performed a literature search to locate all publications reporting on the diagnostic accuracy of CFF for Minimal hepatic encephalopathy.

Data were extracted from 2 × 2 tables or calculated from reported accuracy data.

The team performed a meta-analysis of the collated data for sensitivity, specificity, diagnostic odds ratio (DOR) and summary receiver operator curve analysis.

The diagnostic odds ratio was 10.9
Alimentary Pharmacology & Therapeutics

Prespecified subgroup analysis and meta-regression were also performed.

The researchers identified 9 studies with data for 622 patients.

The team found that the summary sensitivity was 61%, specificity was 79%,  and diagnostic odds ratio was 10.9. 

The area under the receiver operator curve was 0.84.

The heterogeneity of the diagnostic odds ratio was 74%.

Professor Taylor-Robinson's team concludes, "Critical Flicker Frequency has a high specificity and moderate sensitivity for diagnosing minimal hepatic encephalopathy."

"Given the advantages of language independence and being both simple to perform and interpret, we suggest the use of critical flicker frequency as an adjunct to psychometric testing."

Aliment Pharmacol Ther 2013: DOI: 10.1111/apt.12199
15 January 2013

Go to top of page Email this page Email this page to a colleague

 18 May 2013

Advanced search
 17 May 2013 
PCR assay pathogen detection of pathogens stools of travelers
 17 May 2013 
Genetic risk factors for colorectal cancer
 17 May 2013 
Reducing post-ERCP pancreatitis
 16 May 2013 
Risk factors for advanced colonic neoplasia
 16 May 2013 
Depression and anxiety in IBD after surgery
 16 May 2013 
Lipid Biomarkers in hepatocellular carcinoma
 15 May 2013 
H pylori recurrence and human development index
 15 May 2013 
Education benefits to patients with HBV or HCV 
 15 May 2013 
Predicting surgical recurrence of Crohn's disease
 14 May 2013 
Group hypnosis in refractory IBS
 14 May 2013 
Acute kidney injury in liver cirrhosis
 14 May 2013 
Peptic ulcers and psychosocial stress
 13 May 2013 
Bowel functions in IBS 
 13 May 2013 
Venous thromboembolism risk in IBD
 13 May 2013 
Epidemiology of IBS
 10 May 2013 
Esophageal mucosal breaks in GERD
 10 May 2013 
Immunochemical fecal occult blood tests for colorectal cancer screening
 10 May 2013 
Automated stool DNA assay for colorectal neoplasia
 09 May 2013 
HIV and the Severity of HC Virus–Related Liver Disease
 09 May 2013 
Post-polypectomy bleeding with clopidogrel therapy
 09 May 2013 
Rebound acid hypersecretion after PPI treatment
 08 May 2013 
Fecal occult blood tests for colorectal cancer screening
 08 May 2013 
Clostridium difficile Infection guidelines
 08 May 2013 
Revised guidelines for the management of Lynch syndrome 
 07 May 2013 
Clinical management of Lynch syndrome
 07 May 2013 
Colorectal cancer in a vulnerable population
 07 May 2013 
Gluten-free diet in IBS
 06 May 2013 
Regurgitation and quality of life in heartburn responders 
 06 May 2013 
Mucosal healing and ulcerative colitis outcomes 
 06 May 2013 
Orlistat and liver injury
 03 May 2013 
Celiac disease, NIDDM and metabolic syndrome
 03 May 2013 
Targeting microRNA in HCV infection
 03 May 2013 
IBD practice guidelines
 02 May 2013 

Reducing patient discomfort in colonoscopy

 02 May 2013 
Early marker of H. pylori and gastric cancer risk
 02 May 2013 
Gluten-free diet in IBS-diarrhea
 01 May 2013 
H. pylori recurrence and human development index
 01 May 2013 
Long-term success of GUT-directed group hypnosis in IBS
 01 May 2013 
Colorectal polyp size measurement and surveillance
 30 April 2013 
Depression and anxiety after surgery for IBD
 30 April 2013 
Surgery vs medical management for GERD
 30 April 2013 
Weight-adjusted anti-TNF therapy in obese patients with Crohn’s
 29 April 2013 
Peripheral neuropathy screening in IBD
 29 April 2013 
Anti-TNF after abdominal surgery in Crohn's
 29 April 2013 
Colonoscopic post-polypectomy bleeding and clopidogrel
 26 April 2013 
Health-education to prevent worm infections
 26 April 2013 
Barrett’s esophagus with type II diabetes mellitus
 26 April 2013 

Portal vein thrombosis in virus-related cirrhosis

 25 April 2013 
Colonoscopic post-polypectomy bleeding with clopidogrel
 25 April 2013 
Peripheral neuropathy screening in IBD
 25 April 2013 
BMI and IBD risk
 24 April 2013 
Celecoxib and gastric intestinal metaplasia after H. pylori eradication
 24 April 2013 
Cannulation technique and post-ERCP pancreatitis
 24 April 2013 
Esophageal bacterial biofilm changes in GERD
 23 April 2013 
Dietary patterns and esophagogastric cancer
 23 April 2013 
International IBD practice guidelines
 23 April 2013 
Metastatic risk after endoscopic resection of esophageal carcinoma
 22 April 2013 
Nationally placed livers by donation service area
 22 April 2013 
Asian patients with HCV
 22 April 2013 
Esophageal mucosal breaks in GERD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2013 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us